ERBB2 and breast cancer: We next analyzed PRLR gene expression levels in different breast cancer molecular subtypes including TNBC (660 patients), Her-2 (170 patients), luminal A (703 patients) and luminal B (170 patients) using robust single sample predictor classification (RSSPC) in bc-GenExMiner 3.0 database.